Scientists' interest v the public's

Seminars promote patents

Cipla puts US law school on notice     

Kremlin on Tartar sweet

Big tobacco blows new smoke rings

A third front has opened up in their war on Australia’s cigarette packaging rules

WTO members agree to discuss proposal to waive patents on COVID-19 technologies 

The waiver would increase access to technologies crucial to fighting the pandemic

The irrelevance of multilateralism

Rich countries gang up for a more strident intellectual property rights regime

New science policy brings in PPP

Makes provision for public funding of corporate research and development

A treaty to block cheaper drugs

Developed countries to use a geographical advantage to stop generics

Indications of a geographic muddle

Are Geographical Indications safeguarding the interests of growers and artisans?

Let the genes cross borders

National sovereignty over genetic resources could undermine food security

'Microbes can be patented'

Water in a sieve

Don’t confine global resources to national boundaries

A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Biodiversity—India’s other scandal

CAG slams the national biodiversity authority for allowing questionable patents

Free trade will bind India

Legislation for a few

Benefits of the Act that encourages conservation of plants reach few farmers

Yale guide to fighting drug patent barriers

How human rights can be used to challenge oppressive intellectual property laws

Rajasthan opens farm gates

State ties up with Monsanto, other biotech giants to restructure agriculture

Whose germplasm is it?

NBA struggles to frame case against Mahyco in first biopiracy case

Sub-standard drugs bigger problem than counterfeit drugs: health activists

Problem of poor quality drugs cannot be solved with technology alone, they say

Say cheese to Brussels

Letters

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company

US piles on the pressure

Patent law, domestic content rules in solar and ICT policy come under attack